81 related articles for article (PubMed ID: 21705955)
1. Cyclooxygenase-2 polymorphisms and pancreatic cancer susceptibility.
Özhan G; Lochan R; Leathart JB; Charnley R; Daly AK
Pancreas; 2011 Nov; 40(8):1289-94. PubMed ID: 21705955
[TBL] [Abstract][Full Text] [Related]
2. The effect of genetic polymorphisms of cyclooxygenase 2 on acute pancreatitis in Turkey.
Ozhan G; Yanar TH; Ertekin C; Alpertunga B
Pancreas; 2010 Apr; 39(3):371-6. PubMed ID: 19820421
[TBL] [Abstract][Full Text] [Related]
3. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
[TBL] [Abstract][Full Text] [Related]
4. Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis.
Yu KD; Chen AX; Yang C; Qiu LX; Fan L; Xu WH; Shao ZM
Breast Cancer Res Treat; 2010 Jul; 122(1):251-7. PubMed ID: 20033767
[TBL] [Abstract][Full Text] [Related]
5. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.
Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D
Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548
[TBL] [Abstract][Full Text] [Related]
6. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
Zhang X; Miao X; Tan W; Ning B; Liu Z; Hong Y; Song W; Guo Y; Zhang X; Shen Y; Qiang B; Kadlubar FF; Lin D
Gastroenterology; 2005 Aug; 129(2):565-76. PubMed ID: 16083713
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between single nucleotide polymorphisms in the promoter of COX-2 gene and hereditariness to NAFLD].
Cao MB; Yang YX; Dong L
Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):773-7. PubMed ID: 21059296
[TBL] [Abstract][Full Text] [Related]
8. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Mutat Res; 2009 Apr; 663(1-2):52-9. PubMed ID: 19428370
[TBL] [Abstract][Full Text] [Related]
9. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer].
Zhang XM; Miao XP; Tan W; Sun T; Guo YL; Zhao D; Lin DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):119-23. PubMed ID: 16733888
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
11. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
[TBL] [Abstract][Full Text] [Related]
12. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
13. A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer.
Li F; Ren GS; Li HY; Wang XY; Chen L; Li J
Clin Oncol (R Coll Radiol); 2009 May; 21(4):302-5. PubMed ID: 19138835
[TBL] [Abstract][Full Text] [Related]
14. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
15. Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies.
Li Q; Liu L; Liu Y; Zhou H; Yang Z; Yuan K; Min W
Med Oncol; 2015 Jan; 32(1):397. PubMed ID: 25433948
[TBL] [Abstract][Full Text] [Related]
16. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.
Yang H; Gu J; Lin X; Grossman HB; Ye Y; Dinney CP; Wu X
Clin Cancer Res; 2008 Apr; 14(7):2236-44. PubMed ID: 18381966
[TBL] [Abstract][Full Text] [Related]
17. Interaction of cyclooxygenase 2 genotype and smoking habit in Taiwanese lung cancer patients.
Liu CJ; Hsia TC; Wang RF; Tsai CW; Chu CC; Hang LW; Wang CH; Lee HZ; Tsai RY; Bau DT
Anticancer Res; 2010 Apr; 30(4):1195-9. PubMed ID: 20530427
[TBL] [Abstract][Full Text] [Related]
18. Lack of association of the cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphism with risk of cervical cancer in Korean population.
Lee TS; Jeon YT; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():134-42. PubMed ID: 17404026
[TBL] [Abstract][Full Text] [Related]
19. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L
Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597
[TBL] [Abstract][Full Text] [Related]
20. The association between cyclooxygenase-2 (COX-2/PTGS2) gene polymorphism and osteoarthritis.
Güler VG; Yalın S; Berköz M; Cimen OB; Yalın E; Eroğlu P; Kanık A
Eklem Hastalik Cerrahisi; 2011; 22(1):22-7. PubMed ID: 21417982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
